Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.

Blood
Franziska JundtBernd Dörken

Abstract

Immunoglobulin transcription is impaired in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin disease (cHD). We recently demonstrated that defective immunoglobulin promoter transcription correlates with the down-regulation of the B-cell transcription factors Oct2 and BOB.1/OBF.1. These results prompted us to investigate whether immunoglobulin enhancer activity is also impaired in HRS cells and whether as yet unidentified factors could be necessary for immunoglobulin enhancer activity in HRS cells of cHD. Here we analyzed 30 cases of cHD for expression of the Ets family member PU.1 that is known to collaborate with multiple transcription factors and to regulate expression of immunoglobulin genes. We show that PU.1 is not expressed in primary and cultured HRS cells. Reintroduction of PU.1 and Oct2 in cultured HRS cells restored the activity of cotransduced immunoglobulin enhancer constructs. Our study identifies PU.1 deficiency as a recurrent defect in HRS cells that might contribute to their impairment of immunoglobulin transcription.

References

Jan 1, 1992·Molecular and Cellular Biology·J M PongubalaM L Atchison
Jan 13, 1995·The Journal of Biological Chemistry·H SchwarzenbachP Matthias
Nov 1, 1993·Molecular and Cellular Biology·R R RiveraC Murre
Jun 28, 1996·The Journal of Biological Chemistry·H ChenD G Tenen
Jul 1, 1996·The Journal of Experimental Medicine·G H SuM C Simon
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·J M Pongubala, M L Atchison
May 23, 1998·Annual Review of Immunology·A Henderson, K Calame
Apr 22, 1999·Immunology Today·J LloberasA Celada

❮ Previous
Next ❯

Citations

Jan 1, 1996·International Journal of Clinical & Laboratory Research·H J Gruss
Oct 6, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Shereen A Turkistany, Rodney P DeKoter
Oct 14, 2003·Trends in Immunology·Michael A Teitell
Sep 12, 2003·Trends in Immunology·Theodora Papadaki, Kostas Stamatopoulos
May 2, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ryan C McCuneMohammad A Vasef
Oct 15, 2005·The American Journal of Surgical Pathology·Alexandra Traverse-GlehenElaine S Jaffe
May 16, 2006·The American Journal of Surgical Pathology·Sonam PrakashStefania Pittaluga
Nov 29, 2007·Journal of Clinical Pathology·G Kapatai, P Murray
Feb 1, 2003·Journal of Clinical Pathology·S A PileriB Falini
Jan 1, 2009·Mediterranean Journal of Hematology and Infectious Diseases·Giuseppina MassiniStefan Hohaus
Feb 2, 2013·Archives of Pathology & Laboratory Medicine·Nathan D MontgomeryYuri D Fedoriw
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peggy S EisJames E Dahlberg
Nov 7, 2006·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Alexandar Tzankov, Stephan Dirnhofer
Jun 19, 2004·Leukemia & Lymphoma·Stefano A PileriUNKNOWN International Extranodal Lymphoma Study Group
Jan 7, 2006·Leukemia & Lymphoma·Maria BaiPanagiotis Kanavaros
Nov 21, 2007·Expert Review of Molecular Diagnostics·Michele R Roullet, Adam Bagg
Oct 3, 2007·Hematology/oncology Clinics of North America·Stephan Mathas
Nov 13, 2004·The Journal of Pathology·Eva-Maria SchneiderBernd Giebel
Jul 26, 2005·The Journal of Pathology·Joost KluiverAnke van den Berg
Oct 16, 2007·The Journal of Pathology·S TedoldiT Marafioti
Sep 17, 2013·Journal of Cellular Physiology·Rabia IslamHyun-Mo Ryoo
Oct 8, 2003·Hematology·Kostas StamatopoulosAchilles Anagnostopoulos
Nov 6, 2007·Virology·Leah J Anderson, Richard Longnecker
Apr 18, 2018·Immunology and Cell Biology·Randolph B CaldwellHorst Zitzelsberger
Sep 2, 2005·British Journal of Cancer·O HopferS Aebi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.